Fetal growth restriction and subsequent pregnancy risks.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Seminars in Perinatology

• Publication date

  2007-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/J.SEMPERI.2007.03.004PMID 17531894
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.

  2014cited by this paper
• The role of chronic non-specific inflammatory lesions of the placenta in intra-uterine growth retardation.

  2009cited by this paper
• Maternal-fetal medicine.

  2008cited by this paper
• Placental Mesenchymal Dysplasia Is Associated With High Rates of Intrauterine Growth Restriction and Fetal Demise

  2006cited by this paper
• Placental mesenchymal dysplasia is associated with high rates of intrauterine growth restriction and fetal demise: A report of 11 new cases and a review of the literature.

  2006cited by this paper
• Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?

  2006cited by this paper
• Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia.

  2006cited by this paper
• Thrombophilia and Adverse Maternal-Perinatal Outcome

  2006cited by this paper
• Thrombophilia in pregnancy: a systematic review

  2006cited by this paper
• Is Small for Gestational Age a Marker of Future Fetal Survival In Utero?

  2006cited by this paper
• Intravenous immunoglobulin in antiphospholipid syndrome and maternal floor infarction when standard treatment fails: a case report.

  2006cited by this paper
• Familial aggregation of small-for-gestational-age births: the importance of fetal genetic effects.

  2006cited by this paper
• Prenatal Ultrasound Diagnosis, Follow-Up, and Outcome of Congenital Varicella Syndrome

  2006cited by this paper
• Management of antiphospholipid antibody syndrome: a systematic review.

  2006cited by this paper
• Low Birth Weight and Preterm Births: Etiologic Fraction Attributable to Prenatal Drug Exposure

  2005cited by this paper
• Fetal Growth Assessment and Neonatal Birth Weight in Fetuses With an Isolated Single Umbilical Artery

  2005cited by this paper
• A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction.

  2005cited by this paper
• Recognition and prevention of fetal alcohol syndrome.

  2005cited by this paper
• Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial.

  2005cited by this paper
• Smoking in pregnancy revisited: findings from a large population-based study.

  2005cited by this paper
• Pregnancy and Neonatal Outcomes in Women With Eating Disorders

  2005cited by this paper
• ACOG Practice Bulletin #68: Antiphospholipid syndrome.

  2005cited by this paper
• Pregnancy outcome of asthmatic patients: A population-based study

  2005cited by this paper
• Thrombophilic Polymorphisms and Intrauterine Growth Restriction

  2005cited by this paper
• Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder.

  2004cited by this paper
• Perinatal outcome in women with severe pregnancy complications and multiple thrombophilias

  2004cited by this paper
• The common prothrombotic factors in nulliparous women do not compromise blood flow in the feto-maternal circulation and are not associated with preeclampsia or intrauterine growth restriction.

  2004cited by this paper
• Fetal transcerebellar diameter measurement with particular emphasis in the third trimester: a reliable predictor of gestational age.

  2004cited by this paper
• Screening and management of inherited thrombophilias in the setting of adverse pregnancy outcome.

  2004cited by this paper
• Intrauterine growth restriction and genetic predisposition to thrombophilia.

  2004cited by this paper
• Body Mass Index Change Between Pregnancies and Small for Gestational Age Births

  2004cited by this paper
• Maternal thrombophilias are not associated with early pregnancy loss

  2004cited by this paper
• Massive perivillous fibrinoid causing recurrent placental failure

  2003cited by this paper
• Placental abruption in term pregnancies: clinical significance and obstetric risk factors

  2003cited by this paper
• Prenatal detection of velamentous insertion of the umbilical cord: a prospective color Doppler ultrasound study

  2003cited by this paper
• Clinical Significance of Subchorionic and Retroplacental Hematomas Detected in the First Trimester of Pregnancy

  2003cited by this paper
• Absence of association of thrombophilia polymorphisms with intrauterine growth restriction.

  2002cited by this paper
• Women and smoking: a report of the Surgeon General.

  2002cited by this paper
• How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review.

  2002cited by this paper
• Recurrent Pregnancy Loss With Antiphospholipid Antibody: A Systematic Review of Therapeutic Trials

  2002cited by this paper
• Mid‐trimester severe intrauterine growth restriction is associated with a high prevalence of thrombophilia

  2002cited by this paper
• Preventing adverse obstetric outcomes in women with genetic thrombophilia.

  2002cited by this paper
• Antiphospholipid Syndrome in Pregnancy: A Randomized, Controlled Trial of Treatment

  2002cited by this paper
• Pregnancy following placental abruption

  2002cited by this paper
• Genetic screening for maternal uniparental disomy of chromosome 7 in prenatal and postnatal growth retardation of unknown cause.

  2002cited by this paper
• Gestational Cocaine Exposure and Intrauterine Growth: Maternal Lifestyle Study

  2002cited by this paper
• The antiphospholipid syndrome.

  2002cited by this paper
• Women with a history of placental abruption: when in a subsequent pregnancy should special surveillance for a recurrent placental abruption be initiated?

  2001cited by this paper
• Familial thrombophilia and the occurrence of fetal growth restriction.

  2001cited by this paper
• Pregnancy outcomes in women with systemic lupus erythematosus

  2001cited by this paper
• Low-Molecular-Weight Heparin for the Prevention of Obstetric Complications in Women with Thrombophilias

  2001cited by this paper
• Reduction of subcutaneous mass, but not lean mass, in normal fetuses in Denver, Colorado.

  2001cited by this paper
• Relationship Among Placenta Previa, Fetal Growth Restriction, and Preterm Delivery: A Population‐Based Study

  2001cited by this paper
• YIELD AND COSTS OF SCREENING GROWTH-RETARDED INFANTS FOR TORCH INFECTIONS

  2000cited by this paper
• Obstetric history and the risk of placenta previa

  2000cited by this paper
• No evidence of uniparental disomy 2, 6, 14, 16, 20, and 22 as a major cause of intrauterine growth retardation

  2000cited by this paper
• Randomised clinical trials of fish oil supplementation in high risk pregnancies

  2000cited by this paper
• Gestational Outcome in Thrombophilic Women with Recurrent Pregnancy Loss Treated by Enoxaparin

  2000cited by this paper
• Predicting Preeclampsia in the Second Pregnancy from Low Birth Weight in the First Pregnancy

  2000cited by this paper
• Increased frequency of genetic thrombophilia in women with complications of pregnancy.

  1999cited by this paper
• Placental abruption and adverse perinatal outcomes.

  1999cited by this paper
• A history of placental dysfunction and risk of placental abruption.

  1999cited by this paper
• Clinical predictors of fetal outcome in systemic lupus erythematosus.

  1998cited by this paper
• Antenatal diagnosis of velamentous umbilical cord insertion and vasa previa with color Doppler imaging

  1998cited by this paper
• Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

  1997cited by this paper
• The effect of high altitude and other risk factors on birthweight: independent or interactive effects?

  1997cited by this paper
• Fetal growth in multifetal gestation.

  1997cited by this paper
• Etiologies of fetal growth restriction.

  1997cited by this paper
• Perinatal Diagnostic Evaluation of Velamentous Umbilical Cord Insertion: Clinical, Doppler, and Ultrasonic Findings

  1996cited by this paper
• Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone.

  1996cited by this paper
• Decrease in severity of intrauterine growth retardation in subsequent pregnancies

  1995cited by this paper
• Uterine Doppler wave form and the prediction of the recurrence of pre-eclampsia and intra-uterine growth retardation in patients treated with low-dose aspirin.

  1995cited by this paper
• Pregnancy Screening by Uterine Artery Doppler Velocimetry – Which Criterion Performs Best?

  1995cited by this paper
• Famine, third-trimester pregnancy weight gain, and intrauterine growth: the Dutch Famine Birth Cohort Study.

  1995cited by this paper
• Relation between maternal haemoglobin concentration and birth weight in different ethnic groups

  1995cited by this paper
• Prospective Studies of the Association Between Anticardiolipin Antibody and Outcome of Pregnancy

  1995cited by this paper
• Maternal Floor Infarction of the Placenta: Prenatal Diagnosis and Clinical Significance

  1994cited by this paper
• Factors potentiating the smoking‐related risk of fetal growth retardation

  1994cited by this paper
• Placental hstology and fetal blood flow in intrauterine growth retardation

  1994cited by this paper
• Clinical significance and treatment of massive intervillous fibrin deposition associated with recurrent fetal growth retardation.

  1994cited by this paper
• Prenatal Diagnosis of 52 Pregnancies at Risk for Congenital Cytomegalovirus Infection

  1993cited by this paper
• Birth Weight Percentiles by Gestational Age in Canada

  1993cited by this paper
• Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension

  1993cited by this paper
• Fetal Outcome in Lupus Pregnancy: A Retrospective Case-Control Study of 242 Pregnancies in 112 Patients

  1993cited by this paper
• Fetal growth retardation: associated malformations and chromosomal abnormalities.

  1993cited by this paper
• Placental Pathology of Idiopathic Intrauterine Growth Retardation at Term

  1992cited by this paper
• Clinical manifestations of the antiphospholipid syndrome.

  1992cited by this paper
• Natural history of chronic proteinuria complicating pregnancy.

  1992cited by this paper
• Prevention of fetal growth retardation with low‐dose aspirin: Findings of the EPREDA trial

  1991cited by this paper
• The Relationship Between Maternal Hematocrit and Pregnancy Outcome

  1991cited by this paper
• Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis

  1988cited by this paper
• Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis.

  1988cited by this paper
• Congenital malformations and intrauterine growth retardation: a population study.

  1988cited by this paper
• Sonographic spectrum of placental abruption.

  1987cited by this paper
• Effects on infants of a first episode of genital herpes during pregnancy.

  1987cited by this paper
• Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole.

  1987cited by this paper
• Relation of haemoglobin levels in first and second trimesters to outcome of pregnancy.

  1986cited by this paper
• Intrauterine Growth in Twin Pregnancies: Prediction of Fetal Growth Retardation

  1985cited by this paper
• Vascular anomalies of the umbilical cord: I. Obstetric implications.

  1983cited by this paper
• Vascular anomalies of the umbilical cord: I. Obstetric implications.

  1983cited by this paper

• The risks of recurrent small for gestational age infants at term is dependent on the number of previous affected births.

  2021cites this paper
• Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis.

  2021cites this paper
• Fetal Growth Restriction: Recurrence Risks and Counseling

  2018cites this paper
• Placental-Fetal Growth Restriction

  2018cites this paper
• Risk of recurrence of small-for-gestational-age foetus after first pregnancy

  2017cites this paper
• Recurrence risk of low Apgar score among term singletons: a population‐based cohort study

  2014cites this paper
• Differences in risk factors for incident and recurrent small‐for‐gestational‐age birthweight: a hospital‐based cohort study

  2014cites this paper
• Epidemiology of ischemic placental disease: a focus on preterm gestations.

  2014cites this paper
• Role of microRNA in early life placental programming of insulin resistance and metabolic health.

  2014cites this paper
• Maternal origin of 47,XXY and confined placental mosaicism 47,XXY/48,XXY,+13 in an infant conceived through IVF

  2013cites this paper
• Prenatal nicotine exposure enhances the susceptibility to metabolic syndrome in adult offspring rats fed high-fat diet via alteration of HPA axis-associated neuroendocrine metabolic programming

  2013cites this paper
• Recurrence of small-for-gestational-age pregnancy: analysis of first and subsequent singleton pregnancies in The Netherlands.

  2013cites this paper
• Motivators and Barriers to a Healthy Postpartum Lifestyle in Women at Increased Cardiovascular and Metabolic Risk: A Focus-Group Study

  2012cites this paper
• Probability distributions for measures of placental shape and morphology

  2011cites this paper
• Intrauterine growth restriction

  2011cites this paper
• The role of stress in female reproduction and pregnancy: an update

  2010cites this paper
• Diseases of Infancy and Childhood

  2010cites this paper
• Recurrence of fetal growth restriction in singleton and twin gestations

  2009cites this paper
• Immune function in pregnancy: the role of corticotropin-releasing hormone

  2008cites this paper
• The clinical content of preconception care: reproductive history.

  2008cites this paper
• Follow-up of children exposed antenatally to immunosuppressive drugs.

  2008cites this paper
• History of Fetal Growth Restriction Is More Strongly Associated With Severe Rather Than Milder Pregnancy-Induced Hypertension

  2008cites this paper
• Epidemiologic approaches for studying recurrent pregnancy outcomes: challenges and implications for research.

  2007cites this paper